Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Neuroendocrine Carcinoma”

554 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 554 results

Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Not applicableNot Yet RecruitingNCT07645742
What this trial is testing

Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors

Who this might be right for
Cancer (Advanced Stage)
West Virginia University 90
Not applicableActive Not RecruitingNCT06204159
What this trial is testing

Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery

Who this might be right for
Hepatocellular CarcinomaNeuroendocrine Tumors
Abramson Cancer Center at Penn Medicine 12
Not applicableStudy completedNCT03834701
What this trial is testing

Endoscopic Ultrasound-guided RadioFrequency Ablation for the Treatment Pancreatic NeuroEndocrine Neoplasms

Who this might be right for
Neuroendocrine TumorsNeuroendocrine CarcinomaPancreas Neoplasm+1 more
Catholic University of the Sacred Heart 60
Testing effectiveness (Phase 2)Ended earlyNCT01065805
What this trial is testing

Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma

Who this might be right for
Brain CancerCancerSolid Tumor+1 more
AHS Cancer Control Alberta 94
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Early research (Phase 1)Temporarily pausedNCT04714983
What this trial is testing

DNX-2440 for Resectable Colorectal Liver Metastasis

Who this might be right for
Liver MetastasesLiver Metastasis Colon CancerColorectal Cancer+8 more
DNAtrix, Inc. 30
Early research (Phase 1)Study completedNCT00574977
What this trial is testing

Safety Study of Modified Vaccinia Virus to Cancer

Who this might be right for
MelanomaBreast CancerHead and Neck Squamous Cell Cancer+3 more
David Bartlett 26
Testing effectiveness (Phase 2)Study completedNCT01465659
What this trial is testing

Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery

Who this might be right for
Pancreatic Alpha Cell CarcinomaPancreatic Beta Islet Cell CarcinomaPancreatic Delta Cell Carcinoma+2 more
Northwestern University 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT02867592
What this trial is testing

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

Who this might be right for
Adrenal Cortical CarcinomaAlveolar Soft Part SarcomaCentral Nervous System Neoplasm+41 more
National Cancer Institute (NCI) 109
Early research (Phase 1)Study completedNCT04242199
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+9 more
Incyte Corporation 182
Testing effectiveness (Phase 2)Active Not RecruitingNCT03935893
What this trial is testing

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

Who this might be right for
Gastric CancerColorectal CancerPancreatic Cancer+7 more
Udai Kammula 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03157128
What this trial is testing

Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

Who this might be right for
Non-Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+1 more
Eli Lilly and Company 857
Early research (Phase 1)Study completedNCT03195699
What this trial is testing

Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers

Who this might be right for
Breast CancerHead and Neck Squamous Cell CarcinomaNon Small Cell Lung Cancer+5 more
Tvardi Therapeutics, Incorporated 64
Testing effectiveness (Phase 2)Study completedNCT02230176
What this trial is testing

Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II

Who this might be right for
Pancreatic Neuroendocrine Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris 84
Testing effectiveness (Phase 2)Study completedNCT04731467
What this trial is testing

CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerPancreatic Cancer+4 more
Famewave Ltd. 79
Early research (Phase 1)Active Not RecruitingNCT05907304
What this trial is testing

Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations

Who this might be right for
Advanced or Metastatic Solid Tumors
Erasca, Inc. 86
Testing effectiveness (Phase 2)Study completedNCT00131911
What this trial is testing

Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+7 more
National Cancer Institute (NCI) 93
Not applicableLooking for participantsNCT06418204
What this trial is testing

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Who this might be right for
Breast CarcinomaColorectal CarcinomaLung Non-Small Cell Carcinoma+2 more
Wake Forest University Health Sciences 2,000
Not applicableStudy completedNCT03616431
What this trial is testing

Pancreatic Cancer Dietary Assessment Study

Who this might be right for
Pancreatic NeoplasmPancreas AdenocarcinomaWell-Differentiated Neuroendocrine Carcinoma+1 more
The Christie NHS Foundation Trust 112
Load More Results